CB Insights
Technology Market Intelligence
Technology Market Intelligence
Bicycle Therapeutics (Nasdaq: BCYC) is a clinical-stage biopharmaceutical company developing a class of medicines referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short peptides constra...Show all
Company (IPO / Went public)
Phone: +44 (0)1223 497 415
B900 Babraham Research Campus
Cambridge, CB22 3AT
England, United Kingdom
| Total Funding | Date of Last Funding | |
|---|---|---|
| Bicycle Therapeutics | $90M | May 23, 2019 |
| Barrier Therapeutics | $156.2M | Aug 20, 2008 |
| See all 14 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Modulation of structured polypeptide specificity | Oct 08, 2012 | Oct 13, 2020 | Patent |
| Compounds for treating cancer | Jan 05, 2018 | Apr 21, 2020 | Patent |
| Bicyclic peptide ligands specific for mt1-mmp | Oct 29, 2015 | Jan 14, 2020 | Patent |
| Methods for treating cancer | Nov 27, 2017 | Oct 15, 2019 | Patent |
| Novel polypeptides | Oct 28, 2014 | May 21, 2019 | Patent |
